Search PubMed⌕ Search

Biomedical subjects

C F Wolf

Publications and source records attributed to C F Wolf.

40 records · Page 3Linked to original sources
PubMedDate not supplied

Anti-Sdx: a "new" auto-agglutinin related to the Sda blood group.

Two examples of a "new" IgM saline-agglutinating auto-antibody are described. The antibodies bind complement, have the ability to cause in vivo hemolysis, and are most active at room temperature at a pH of about 6.5. Despite tests on more than 5,000 people, no nonreactive cell sample has been found. The reactive antigen is not denatured by neuraminidase, papain, or ficin, and is present on i adult red blood cells. The antibodies appear to be slightly inhibited by human saliva and milk, and more convincingly inhibited by urine from Sd(a+) persons. They are not inhibited by urine from Sd(a-) persons, but are strongly inhibited by guinea pig urine. The serologic characteristics indicate a relationship to the Sda blood group and the auto-antibody has been named antiSdx. Sdx antigen is present on red blood cells from some higher primates and is absent from rabbit, rhesus monkey, dog and sheep cells.

ABO Blood-Group System↗
PubMedDate not supplied

Autoimmune hemolytic anemia with predominance of IgA autoantibody.

A 71-year-old woman with severe autoimmune hemolytic anemia had negative direct antiglobulin tests using commercial broad spectrum antisera. Her unwashed cells agglutinated spontaneously in the potentiating medium polyvinylpyrrolidone (PVP) solution or in hexadimethrine bromide (Polybrene) solution. A strongly positive direct antiglobulin test was obtained with specific antihuman IgA sea with or without PVP. In PVP solution, small amounts of IgG, IgM, and complement components were also detected on her cells. The findings illustrate the ability of anti-human IgA to detect autoimmune red blood cell sensitization when other immunoglobulin classes of autoantibody are below detectable levels or absent. Also illustrated is the value of PVP and Polybrene in detecting agglutination in the evaluation of "antiglobulin negative" hemolytic anemia.

Aged↗
PubMedDate not supplied

Induction of donor-specific immune modulation and successful renal transplantation with a simplified method of donor-specific blood transfusion.

We developed a new method of donor-specific blood transfusion (DST) for prospective kidney transplant recipients from a living related donor. Forty-four patients were transfused with 100 ml of one-haplotype matched kidney donor's whole blood at 1, 8, and 15 days after its storage. Ten of these patients received azathioprine (1.5 mg/kg per day) in addition to DST. After DST, three patients (6.8%) developed donor-specific lymphocytotoxic antibodies. The incidence of sensitization was not different between azathioprine-treated and untreated patients. Following DST, donor-specific mixed lymphocyte culture (MLC) was significantly suppressed without any accelerated (secondary type) response in early MLC. Subsequently, 24 patients received a kidney transplant from the donor. Graft survival rates were 96% and 90% at 12 and 24 months, respectively. Nine additional patients, seven from a two-haplotype matched sibling and two from a no-haplotype matched sibling also received DST. None of these patients became sensitized following DST, and all have functioning grafts for 6 to 18 months. This study indicates that 100 ml of stored whole blood DST three times at weekly intervals is a practical, less immunizing, and effective approach to enhance graft survival in recipients of a living related donor graft, DST produces donor-specific adaptive responses that might be conductive to successful graft outcome, and this protocol could be used in sibling donor-recipient pairs who do not share a haplotype.

Adult↗